everolimus
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
23 FDA-registered drug labelers
Amneal Pharmaceuticals NY LLC
Ascend Laboratories, LLC
Aurobindo Pharma Limited
Biocon Limited
Biocon Pharma Inc.
Breckenridge Pharmaceutical, Inc.
BrightGene Bio-Medical Technology Co., Ltd.
Chunghwa Chemical Synthesis & Biotech. Ltd
Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd.
CONCORD BIOTECH LTD
Dr. Reddy's Laboratories Limited
Farmhispania, S.A.
Hikma Pharmaceuticals USA Inc.
MSN Laboratories Private Limited
NATCO PHARMA LIMITED
NorthStar RxLLC
Novartis Pharma Stein AG
Novartis Pharmaceuticals Corporation
Novugen Pharma (USA) LLC.
Par Health USA, LLC
ScinoPharm Taiwan Ltd.
Teva Pharmaceuticals USA, Inc.
Upsher-Smith Laboratories, LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 5 drug and cosmetic product listings (FDA).
- •Zortress
- •Afinitor
- •Everolimus
- •Afinitor Disperz
- •Torpenz
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Everolimus Tablet
11/03/2025to be discontinued
Everolimus Tablet
03/02/2026to be discontinued
Everolimus Tablet
01/06/2026Chemical Identity
CAS159351-69-6
PubChem CID6442177
DTXSIDDTXSID0040599
FormulaC53H83NO14
Mol. Weight958.2 g/mol
SMILESCC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC
Data Sources
64421772026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/everolimus/cids/JSON
Archive: data/sources/pubchem_name/everolimus.json
CAS 159351-69-62026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 159351-69-62026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json